Antibiotic susceptibility of clinical Burkholderia pseudomallei isolates in northeast Thailand during 2015-2018 and the genomic characterization of β-lactam-resistant isolates
Melioidosis is an often fatal infection in tropical regions caused by an environmental bacterium, Burkholderia pseudomallei. Current recommended melioidosis treatment requires intravenous β-lactam antibiotics such as ceftazidime (CAZ), meropenem (MEM), or amoxicillin-clavulanic acid (AMC) and oral t...
Main Authors: | Hii, SYF, Tandhavanant, S, Phunpang, R, Ekchariyawat, P, Saiprom, N, Chewapreecha, C, Seng, R, Thiansukhon, E, Morakot, C, Sangsa, N, Chayangsu, S, Chuananont, S, Tanwisaid, K, Silakun, W, Buasi, N, Chaisuksant, S, Hompleum, T, Chetchotisakd, P, Day, NPJ, Chantratita, W, Lertmemongkolchai, G, West, TE, Chantratita, N |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Society for Microbiology
2021
|
Similar Items
-
Blood transcriptomics to characterize key biological pathways and identify biomarkers for predicting mortality in melioidosis
by: Yimthin, T, et al.
Published: (2020) -
Longitudinal profiling of plasma cytokines in melioidosis and their association with mortality: a prospective cohort study
by: Kaewarpai, T, et al.
Published: (2019) -
Genetic diversity, determinants, and dissemination of Burkholderia pseudomallei lineages implicated in melioidosis in Northeast Thailand
by: Seng, R, et al.
Published: (2024) -
Genetic diversity, determinants, and dissemination of Burkholderia pseudomallei lineages implicated in melioidosis in northeast Thailand
by: Seng, R, et al.
Published: (2023) -
Susceptibility of clinical isolates of Burkholderia pseudomallei to a lipid A biosynthesis inhibitor.
by: Sengyee, S, et al.
Published: (2017)